Biotech · Private company
Stelexis BioSciences
Track this companyFree. Adds Stelexis BioSciences to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Azacitadine (AZA)Phase 1 · AML, AdultClinicalTrials.gov · fetched Nov 12, 2026
- EganelisibPhase 1 · AML, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Eganelisib in combination with azacitidinePhase 1 · AML, AdultClinicalTrials.gov · fetched Nov 12, 2026
- Eganelisib in combination with cytarabinePhase 1 · AML, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML/HR-MDS and in Combination With Azacitidine in Previously Untreated HR-MDSPHASE1 · RECRUITING · started Apr 28, 2025ClinicalTrials.gov NCT06533761 · fetched Nov 12, 2026